GrayMatters Health Expands US Executive Team, Including Appointment of Dr. Aron Tendler as Chief Medical Officer
HAIFA, Israel, Sept. 26, 2023 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, today announced the expansion of its executive team in the United States (US) with the appointment of psychiatrist Dr. Aron Tendler to Chief Medical Officer. In addition, Pam Schwartz joins as VP Marketing and Scott Blackman joins as Director of Market Access and Provider Success, to rollout the company's flagship device, Prism for PTSD, in clinics throughout the country.
- HAIFA, Israel, Sept. 26, 2023 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, today announced the expansion of its executive team in the United States (US) with the appointment of psychiatrist Dr. Aron Tendler to Chief Medical Officer.
- With more than 13 million Americans living with PTSD, there is a pressing need to augment existing therapies and empower patients with more control over their mental health.
- It is based on GMH's proprietary amygdala-derived EEG-fMRI-Pattern (EFP) biomarker technology, which applies advanced statistical models that register fMRI data with EEG data.
- "We are thrilled to have these experienced professionals join our mission to drive improved mental health care forward with our innovative technology," said Oded Kraft, Co-Founder and CEO of GrayMatters Health.